unknown
Stage
1
Investors
About
Knocking down devastation. Inserting hope. At iECURE, we believe in vivo gene editing is the answer to meeting this immense patient need, and we believe reversing the course of these conditions is now within reach.
Explore iECURE's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.